Thyrotoxic periodic paralysis (TPP) is a disease characterized by sudden onset and muscle paralysis. It occurs in the setting of hypokalemia of thyrotoxicosis. Cases of TPP induced by a glucocorticoid such as prednisolone or methylprednisolone have been reported. We report on two patients, each of whom received a dexamethasone injection and subsequently developed TPP. Both patients experienced sudden, flaccid paralysis of both extremities after the injection but recovered completely after receiving a potassium replacement. Laboratory results revealed thyrotoxicosis. The patients were diagnosed with Graves' disease and discharged after receiving treatment with methimazole and propranolol. This report provides the clinical description of TPP induced by dexamethasone injection. These cases suggest that clinicians must consider the presence of hyperthyroid disease in patients who develop acute paralysis after treatment with a glucocorticoid, even in the absence thyrotoxic symptoms. Furthermore, physicians should be aware that TPP can occur even in response to dexamethasone used for treatment of thyrotoxic crisis or Graves' ophthalmopathy. (Endocrinol Metab 27:299-302, 2012) 
INTRODUCTION
Thyrotoxic periodic paralysis (TPP) is a clinical syndrome characterized by recurrent and reversible muscle weakness. The condition is rare in Western populations but is relatively common amongst Asians, especially among men. The symptoms usually involve the lower limbs but may progress to the upper limbs and respiratory muscles in a severe attack; however, this is rare [1] . Attacks of weakness are commonly precipitated by meals high in carbohydrates, high-salt diets, and alcohol. These attacks may also occur during rest following prolonged exercise [1] . In addition, hypokalemia can be induced by glucocorticoid injection. Recently, cases of TPP induced by prednisolone or methylprednisolone were reported [2] [3] [4] [5] .
We report on two patients with TPP induced by dexamethasone injection.
CASE REPORTS

Case 1
A 37-year-old man visited the emergency department complaining of leg muscle weakness. He had previously developed a rash that covered his whole body, for which he had gone to a nearby hospital the day before, where he received an injection of 10 mg dexamethasone. He woke early in the morning the next day with weakness in his lower extremities. He said that he had not experienced similar symptoms in the past. He had no history or family history of similar conditions. At the time of presentation to the emergency room, his body temperature was 36.8°C; respiratory rate, 20/min; pulse rate, 109/min; and blood pressure, 120/80 mmHg.
He had an acute, ill-looking appearance but was mentally alert. He said that he had experienced no weight loss, heat intolerance, or excess sweating. Physical examination revealed that his thyroid gland was of normal size and contained no palpable mass. Neurologic examination revealed a muscle-strength level of two out of five in both lower extremities. The muscle strength of his upper extremities was normal, and deep tendon reflexes were diminished. (Table 1) . Electrocardiogram showed sinus tachycardia and ST depression. Ultrasonographic examination showed that the thyroid gland was within the normal size range but that the thyroid parenchyma had coarse echogenicity. Thyroid uptake and technetium and radioactive iodine scanning also revealed a normal-sized thyroid, with increased technetium uptake and normal radioactive iodine uptake (19.2% at 24 hours). We initially diagnosed diffuse toxic goiter due to the relatively decreased iodine uptake following steroid injection. The patient recovered fully after potassium replacement. He was then diagnosed with Graves' disease and discharged after he was treated with methimazole and propranolol. In the 6 months since then, he has been taking methimazole and has not experienced paralysis.
Case 2
A 35-year-old man visited the emergency department complaining of muscle weakness in both the lower and upper extremities.
Two years ago, he had been diagnosed with Graves' disease and been taking medication to treat it until 6 months before presenting to the emergency room. Two months before presenting to the emergency room, he had experienced back pain and a tingling sensation in both legs, for which he had gone to a nearby hospital. The orthopedist suspected disc herniation after inspection and injected 5 mg dexamethasone. Thereafter, the patient had experienced weakness in his lower and upper extremities. Upon presenting to the emergency room, he said he had no history of similar paralysis, and there was no family history of muscle paralysis. His body temperature was 36.8°C; respiratory rate, 20/min; pulse rate, 98/min; and blood pressure, 130/80 mmHg. He had an acute, ill-looking appearance but was mentally alert. He said that he had experienced weight loss, heat intolerance, and excess sweating 2 months ago. Symptoms of thyrotoxicosis may be mild. Attacks of weakness are commonly precipitated by meals high in carbohydrates, a high-salt diet, alcohol intake, and prolonged exercise [1] . Other risk factors include acetazolamide use, trauma, cold exposure, infection, menses, emotional stress, and steroid use [7] . Recently, cases of TPP induced by prednisolone or methylprednisolone use have been reported [2] [3] [4] [5] . However, no cases of TPP induced by dexamethasone injection had been reported thus far.
The pathogenesis of TPP is not well understood. We do know that low potassium levels are caused by a rapid and massive shift of potassium into the cells. It is thought that this results from increased Na + /K + -ATPase pump activity in skeletal muscle, which is caused by the thyroid hormone [1] . In addition, Na + /K + -ATPase pump activity can be increased by direct stimulation with β-adrenergic hormones, insulin, insulin-like growth factor 1, and amylin [3, 8, 9] . As a result, the enhanced adrenergic response caused by thyroid hormone exacerbates hypokalemia [1, 3] . Glucocorticoid is uncommonly used to treat conditions such as thyrotoxic crisis or ophthalmopathy. When thyrotoxic patients are treated with glucocorticoid, it can induce hypokalemia by shifting potassium into the cells through several mechanisms [4, 5] . These include steroid-induced hyperinsulinemia and an increased Na 
